: Nortapentadol, Urine, Qualitative Screen
: This test screens a urine sample for nortapentadol, a breakdown product (metabolite) of the pain medication tapentadol. A qualitative screen reports whether nortapentadol is detected rather than giving an exact amount.
[": A nortapentadol urine screen indicates whether the tapentadol metabolite is present in the sample, but it is a screening result that may need confirmation."]
Key facts at a glance
- LOINC
- 89306-5
- Short code
- Nortapentadol Ur Ql Scn
- Synonyms
- Nortapentadol Ur Ql Scn
- Category
- chemistry
- Sample
- urine
- Container
- Sterile urine container
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- screen
- Specimen volume
- 10 mL
- Stability
- Room temperature: 2h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 4–24 hours
- Order
- routine
: What This Test Measures
: Nortapentadol is formed in the body when tapentadol, a prescription pain reliever, is processed. This test looks for nortapentadol in urine using a qualitative (detected or not detected) screening approach. It does not measure a precise level.
: Why It May Be Ordered
: A healthcare provider may order this screen to check whether tapentadol has been used, for example in medication monitoring, pain-management programs, or situations where confirming adherence or possible use is important. Results are interpreted together with your medical history and other information.
: How the Sample Is Collected
: The test uses a urine specimen, typically collected in a private collection setting according to the requesting program's instructions. Follow any specific directions you are given about timing and sample handling.
: What Results Mean
: A "detected" result means nortapentadol was found in the sample, suggesting tapentadol use. A "not detected" result means it was not found at the screen's limit. Screening results are preliminary; unexpected or important findings are usually confirmed with a more specific method, and results should always be discussed with your provider.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
: Urine drug screening for tapentadol metabolite can support medication adherence monitoring and help identify use of this prescription opioid. Because qualitative screens can be affected by timing, dose, hydration, and test cutoffs, and because they are not definitive on their own, results should be interpreted by a clinician and confirmed when clinically necessary.
Short name
: Nortapentadol Screen
Frequently asked questions
: Does a detected result mean I definitely took tapentadol?
: Can the timing of my sample affect the result?
: Is this an exact measurement of the drug level?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy